This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hunter, A. Articles by McClure, N. Search for Related Content PubMed PubMed Citation Articles by Hunter, A. Articles by McClure, N. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Risk Pregnancy Related Collections Other hypertension Endothelium/vascular type/nitric oxide

(Hypertension. 2000;36:965.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Serum Levels of Vascular Endothelial Growth Factor in Preeclamptic and Normotensive Pregnancy

Alyson Hunter; Mark Aitkenhead; Carolyn Caldwell; Geoffrey McCracken; David Wilson; Neil McClure

From the Department of Obstetrics and Gynaecology (A.H., M.A., C.C., G.M., N.M.) and Department of Anatomy (D.W.), The Queen’s University of Belfast, Northern Ireland.

Correspondence to Alyson Hunter MRCOG, Department of Obstetrics and Gynaecology, Institute of Clinical Science, The Queen’s University of Belfast, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland. E-mail alyson{at}net.ntl.com

Abstract—The purpose of these studies was first to determine if vascular endothelial growth factor (VEGF), a vascular permeability agent, is increased in the serum of women with preclinical and clinical preclampsia (PE), and second to determine how these levels change after delivery. Twenty preeclamptic and 25 normotensive women at term consented to have blood taken pre- and post-delivery. Ten preeclamptic, 10 gestational hypertensive, and 28 normotensive women had blood collected respectively at 12, 20, and 30 weeks gestation and predelivery. Serum was extracted from all samples, and VEGF concentrations were determined by radioimmunoassay. Predelivery, the median serum VEGF concentration in the preeclamptic group was 51.7 ng/mL, and in the control group the concentration was 13.9 ng/mL (P<0.0001). Serum VEGF concentrations fell within 24 hours of delivery in both groups, which resulted in median values of 3.8 ng/mL and 3.2 ng/mL respectively (P<0.3). At 12 and 20 weeks, there was no significant difference between the serum VEGF concentrations in the 3 groups (P<0.3, 0.052 respectively). At 30 weeks, prior to the onset of clinical PE, the serum VEGF levels in the eventual preeclamptic group were elevated significantly compared with the gestational hypertensive and normotensive groups (P<0.001). Predelivery serum VEGF concentrations were significantly elevated in the preeclamptic group and were similar to those in the first study (P<0.0001). These findings suggest that VEGF may be important in the pathophysiology of PE and has the potential to act as a preclinical marker for the condition.

Key Words: vascular endothelial growth factor • PE • endothelium • serum • radioimmunoassay